Clearwater Orthotics & Prosthetics | |
801 Bryden Ave, Lewiston, Idaho 83501 | |
(208) 798-4605 |
Name | Clearwater Orthotics & Prosthetics |
---|---|
Organization Name | Clearwater Orthotics And Prosthetics, Llc |
Location | 801 Bryden Ave, Lewiston, Idaho 83501 |
Type | Prosthetic/Orthotic Supplier |
Phone | (208) 798-4605 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Scripps Research, a globally recognized nonprofit biomedical research institute, today announced a collaborative research program with Tempus, a leader in precision medicine and artificial intelligence, to develop a predictive model of glucose responses in people with and without type 2 diabetes.
Affiliated Medical Billing, an affiliate of Yeo & Yeo CPAs & Business Consultants, will host ICD-10-CM training sessions at locations throughout Michigan beginning in January 2014.
The U.S. Food and Drug Administration today approved Incivek treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies. Incivek is approved for use with interferon therapy made up of peginterferon alfa and ribavirin.
Today, the U.S. Food and Drug Administration granted accelerated approval to Polivy (polatuzumab vedotin-piiq), in combination with the chemotherapy bendamustine and a rituximab product (a combination known as "BR"), to treat adult patients with diffuse large B-cell lymphoma (DLBCL) that has progressed or returned after at least two prior therapies.
Ongoing follow up of the surviving patients from the phase I study of ADXS11-001 for the treatment of cervix cancer failures conducted by Advaxis, Inc.,, the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, has shown that two of fifteen treated patients or 13.3% are still alive 1,248 and 1,128 days after receiving their initial dose.
› Verified 4 days ago
NPI Number | 1285852004 |
Organization Name | CLEARWATER ORTHOTICS AND PROSTHETICS, LLC |
Type | Prosthetic/Orthotic Supplier |
Address | 801 Bryden Ave, Lewiston, ID 83501 |
Phone Number | 208-798-4605 |
News Archive
Scripps Research, a globally recognized nonprofit biomedical research institute, today announced a collaborative research program with Tempus, a leader in precision medicine and artificial intelligence, to develop a predictive model of glucose responses in people with and without type 2 diabetes.
Affiliated Medical Billing, an affiliate of Yeo & Yeo CPAs & Business Consultants, will host ICD-10-CM training sessions at locations throughout Michigan beginning in January 2014.
The U.S. Food and Drug Administration today approved Incivek treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies. Incivek is approved for use with interferon therapy made up of peginterferon alfa and ribavirin.
Today, the U.S. Food and Drug Administration granted accelerated approval to Polivy (polatuzumab vedotin-piiq), in combination with the chemotherapy bendamustine and a rituximab product (a combination known as "BR"), to treat adult patients with diffuse large B-cell lymphoma (DLBCL) that has progressed or returned after at least two prior therapies.
Ongoing follow up of the surviving patients from the phase I study of ADXS11-001 for the treatment of cervix cancer failures conducted by Advaxis, Inc.,, the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, has shown that two of fifteen treated patients or 13.3% are still alive 1,248 and 1,128 days after receiving their initial dose.
› Verified 4 days ago
NPI Number | 1699786525 |
Organization Name | CLEARWATER ORTHOTICS & PROSTHETICS |
Type | Prosthetic/Orthotic Supplier |
Address | 801 Bryden Ave, Lewiston, ID 83501 |
Phone Number | 818-357-5732 |
News Archive
Scripps Research, a globally recognized nonprofit biomedical research institute, today announced a collaborative research program with Tempus, a leader in precision medicine and artificial intelligence, to develop a predictive model of glucose responses in people with and without type 2 diabetes.
Affiliated Medical Billing, an affiliate of Yeo & Yeo CPAs & Business Consultants, will host ICD-10-CM training sessions at locations throughout Michigan beginning in January 2014.
The U.S. Food and Drug Administration today approved Incivek treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies. Incivek is approved for use with interferon therapy made up of peginterferon alfa and ribavirin.
Today, the U.S. Food and Drug Administration granted accelerated approval to Polivy (polatuzumab vedotin-piiq), in combination with the chemotherapy bendamustine and a rituximab product (a combination known as "BR"), to treat adult patients with diffuse large B-cell lymphoma (DLBCL) that has progressed or returned after at least two prior therapies.
Ongoing follow up of the surviving patients from the phase I study of ADXS11-001 for the treatment of cervix cancer failures conducted by Advaxis, Inc.,, the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, has shown that two of fifteen treated patients or 13.3% are still alive 1,248 and 1,128 days after receiving their initial dose.
› Verified 4 days ago
News Archive
Scripps Research, a globally recognized nonprofit biomedical research institute, today announced a collaborative research program with Tempus, a leader in precision medicine and artificial intelligence, to develop a predictive model of glucose responses in people with and without type 2 diabetes.
Affiliated Medical Billing, an affiliate of Yeo & Yeo CPAs & Business Consultants, will host ICD-10-CM training sessions at locations throughout Michigan beginning in January 2014.
The U.S. Food and Drug Administration today approved Incivek treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies. Incivek is approved for use with interferon therapy made up of peginterferon alfa and ribavirin.
Today, the U.S. Food and Drug Administration granted accelerated approval to Polivy (polatuzumab vedotin-piiq), in combination with the chemotherapy bendamustine and a rituximab product (a combination known as "BR"), to treat adult patients with diffuse large B-cell lymphoma (DLBCL) that has progressed or returned after at least two prior therapies.
Ongoing follow up of the surviving patients from the phase I study of ADXS11-001 for the treatment of cervix cancer failures conducted by Advaxis, Inc.,, the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, has shown that two of fifteen treated patients or 13.3% are still alive 1,248 and 1,128 days after receiving their initial dose.
› Verified 4 days ago
Owl Home Medical Type: Long Term Care Pharmacy Location: 720 16th Ave, Lewiston, Idaho 83501 Phone: (208) 743-7766 | |
Rite Aid Pharmacy 05408 Type: Medicare Supplier Location: 1904 19th Ave, Lewiston, Idaho 83501 Phone: (208) 743-9127 | |
Walgreens #2679 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2102 Nez Perce Dr, Lewiston, Idaho 83501 Phone: (208) 743-4434 | |
Sav-on Pharmacy #238 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1024 21st St, Lewiston, Idaho 83501 Phone: (208) 743-1529 | |
Rosauers Pharmacy #33 Type: Pharmacy Location: 332 Thain Rd, Lewiston, Idaho 83501 Phone: (208) 743-6511 |